Clinical Trial Update: Immunotherapy in Eyelid Viral Papilloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating immunotherapy for eyelid viral papilloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eyelid Viral Papilloma

Snippet

Sponsor: Zagazig University | Conditions: Eye Infections | Phase 2 | Status: COMPLETED